Press Releases
Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY in Children 5 to <12 Years of Age in the European Union
Pfizer Inc. and BioNTech SE announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a...
Drug Research
Nykode Therapeutics Selects BioConnection to Manufacture Lead Vax Candidate
Nykode Therapeutics, a clinical-stage biopharmaceutical company dedicated to the discovery and development of vaccines and novel immunotherapies, announced that it has entered into a...
Drug Research
Lonza and Bioqube Ventures Sign a Framework Agreement for the Future Development of Biologics and Small Molecules for Bioqubes Portfolio Companies
Bioqube Ventures, a European venture capital firm with a dual investment model including venture creation, and Lonza, a global development and manufacturing partner to...
Drug Research
Valneva Signs Purchase Agreement with European Commission for its Inactivated COVID-19 Vaccine VLA2001
Valneva SE, a specialty vaccine company, today announced that it has signed an Advance Purchase Agreement (APA) with the European Commission (EC) to supply...
Clinical Trials
Emmes Announces Completion of Third ACTT Clinical Trial for COVID-19
Emmes announced that it conducted the data and statistical analysis for the third iteration of the Adaptive COVID-19 Treatment Trial (ACTT-3), using its proprietary...
Press Releases
GreenLight Biosciences and Samsung Biologics announce collaboration to build capacity for messenger RNA Vaccine Manufacturing
GreenLight Biosciences, a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible for human health and agriculture, and Environmental Impact Acquisition...
Clinical Trials
Ascelia Pharma presents study showing comparable efficacy of Orviglance lesion visualization and detection to Gadolinium
Ascelia Pharma AB is presenting a study in which Orviglance® (manganese chloride tetrahydrate, former working name Mangoral) was compared against a gadolinium-based contrast agent...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read